Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cardiac Mapping Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.
The global landscape of cardiac health is rapidly evolving with significant strides in technological innovation and a growing awareness of cardiovascular diseases. As heart-related complications continue to rise, state-of-the-art solutions are becoming increasingly vital in diagnosing and treating patients effectively.
Responding to this imperative need, recent analysis forecasts an expansion within the cardiac mapping market, projecting a compound annual growth rate (CAGR) of 6.28% from 2024 to 2034.
Emergence of Advanced Cardiac Mapping Devices Catalyzes Market Growth
Enhancements in cardiac mapping systems are offering groundbreaking capabilities for arrhythmia mapping, particularly for complex conditions such as Atrial Fibrillation (AFib) and Atrial Flutter. These technological advancements are not only improving patient outcomes but are also streamlining processes for electrophysiologists. Innovations in the field, such as the OCTARAY Mapping Catheter with TRUEref Technology, are set to propel the industry forward, enabling rapid and precise cardiac arrhythmias mapping.
Key Market Segments Point to Diversified Growth and Opportunities
Contact cardiac mapping systems have garnered significant attention, leading the market in revenue generation due to their precise localization capabilities within a three-dimensional environment. With regulatory approvals, such as Abbott's EnSite X EP System with Omnipolar Technology, the segment shows robust growth potential.
Furthermore, non-contact cardiac mapping systems are anticipated to witness the fastest growth rate, underpinned by a surge in innovative product launches designed to enhance diagnostic accuracy.
Cardiac Mapping Systems by Type:
- Non-Contact Cardiac Mapping Systems
- Contact Cardiac Mapping Systems
- Basket Catheter Mapping
- Electroanatomical Mapping
- Traditional Endocardial Catheter Mapping
Cardiac Mapping Systems by Indication:
- Atrial Flutter
- Atrial Fibrillation
- Other
Cardiac Mapping Systems by End-user:
- Diagnostic Centers
- Hospitals & Clinics
- Ambulatory Surgical Centers
Hospitals & Clinics Lead the Way in Providing Advanced Cardiac Care
Hospitals and clinics remain the pivotal end-users in the cardiac mapping market, utilizing the latest technologies to offer superior cardiovascular care. Innovations like Vektor Medical's FDA-approved vMap system underscore the sector's move towards more sophisticated and precise cardiac care. Ambulatory Surgical Centers (ASCs) are also gaining traction, offering outpatient cardiac procedures paired with favorable reimbursement scenarios and improved patient outcomes.
Regional Growth Dynamics: North America and Europe at the Forefront
North America holds a commanding position in the global market, attributed to its high stake in cardiac disease prevalence, healthcare spending, and a series of product launches coupled with favorable regulatory sanctions. Major advancements, such as Medtronic's Affera Mapping and Ablation System, exemplify the technological progress within the region.
On the other hand, Europe is projected to experience the fastest growth rate. The region's focus on technological development, coupled with an increasing incidence of cardiac disorders, mergers, and acquisitions amongst market players, is creating fertile ground for expansion. Notably, Medtronic's acquisition of Affera, Inc., emphasizes an enriched cardiac ablation portfolio that is resonating well within the European healthcare ecosystem.
The detailed report enunciates the expansive growth expected in the cardiac mapping market, examining key segments and emerging trends. A comprehensive analysis of the influential factors is provided, addressing the needs of stakeholders across the healthcare continuum.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value (USD) in 2023 | $3.57 Billion |
| Forecasted Market Value (USD) by 2034 | $6.98 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
Companies Profiled
- Johnson and Johnson (Biosense Webster)
- Koninklijke Philips
- Abbott Laboratories
- Acutus Medical Inc.
- BioSig Technologies
- EPMap Systems
- Kardium Inc.
- Medtronic Plc.
- Lepu Medical Technology
- Boston Bioscientific Corporation
- APN Healthcare
- MicroPort Scientific Corporation
For more information about this report visit https://www.researchandmarkets.com/r/cwe7b8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
